Abstract
An in vivo voltammetric technique was used to monitor dopamine (DA) release in the 6-hydroxydopamine (6-OHDA)-lesioned rat striatum reinnervated by grafts of ventral mesencephalon containing DA neurons. Extracellular levels of DA were measured during the administration of D1 or D2 DA receptor antagonists. In addition, changes in DA levels induced by agonists and antagonists of excitatory amino acid (EAA) receptors were studied to verify the possible existence of a host glutamatergic control on the grafted DA cells in the ‘transplanted’ rats. Two months after the grafts were performed, the voltammetric signal measured under baseline conditions in the grafted striata was found to be almost similar to that recorded on the contralateral control side. Likewise, in another group of transplanted rats, the turnover of the amine, as expressed by the DOPAC/DA tissue level ratio, was found to have become “normalized” after grafting, compared with the lesion-only group. The increase in the voltammetric signal observed after administering the D2 antagonist sulpiride (100 mg/kg i.p.) was lower in the grafted striata than on the contralateral side, however. This suggests that some D2 autoreceptor subsensitivity may have helped to maintain the baseline level of dopaminergic transmission. Adaptive processes of this kind might compensate for the partial DA reinnervation of the host striatum found to occur on the basis of the tyrosine hydroxylase immunostaining patterns. After administration of either the D1 antagonist SCH 23390 (0.1 mg/kg s.c.), or injection of EAA receptor agonists-1-glutamate, quisqualate and N-methyl-d-aspartate (all 10 nmol i.c.v.) — and antagonists — amino-phosphono-valeric acid (10 nmol i.c.v.) and dizocilpine (MK801, 0.2 mg/kg i.p.) — no significant differences between the two striata were detected in the voltammetric signals. These results suggest that, in the grafted rats, neurons belonging to the host population, such as the striatal cells bearing D1 receptors or the corticostriatal afferents presumed to contain glutamate, might modulate the DA levels, as was found to occur under normal conditions.
Similar content being viewed by others
References
Abraini JH, Fechtali T, Rostain JC (1992) Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors. Neuroscience 50:395–402
Adams RN (1990) In vivo electrochemical measurements in the CNS. Prog Neurobiol 35:297–311
Bal A, Savasta M, Chritin M, Mennicken F, Abrous DN, Le Moal M, Feuerstein C, Herman JP (1993) Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic nigrostriatal pathway: a quantitative in situ hybridization study. Mol Brain Res 18:221–227
Baruch P, Artaud F, Godeheu G, Barbeito L, Glowinski J, Cheramy A (1988) Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience 25:889–898
Bolam JP, Somogyi P, Takagi H, Fodor I, Smith AD (1983) Localization of substance P-like immunoreactivity in neurons and nerve terminals in the neostriatum of the rat: a correlated light and electron microscopic study. J Neurocytol 12:325–344
Björklund A (1992) Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2:683–689
Björklund A, Lindvall O, Isacson O, Brundin P, Wictorin K, Strecker RE, Clarke D, Dunnett SB (1987) Mechanisms of action of intracerebral neural implants: studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci 10:509–516
Cheramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus. II Facilitatory or inhibitory influence of l-glutamate. Neuroscience 19:1081–1090
Chritin M, Savasta M, Mennicken F, Bal A, Abrous DN, Le Moal M, Feurstein C, Herman JP (1992) Intrastriatal dopamine-rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: a quantitative in situ hybridisation study. Eur J Neurosci 4:663–672
Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK (1991) Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra. Exp Neurol 111:282–292
De groot J (1959) The rat brain in stereotaxic coordinates. Verhandelingen der Kononklijke Nederlandse Akademie Van Weterneschappen. Afd. Naturkunde N.V. Noord-hollansche Witgecers Maatschappig, Amsterdam
Doucet G, Murata Y, Brundin P, Bosler O, Mons N, Geffard M, Ouimet CC, Björklund A (1989) Host afferents into instrastriatal transplants of fetal ventral mesencephalon. Exp Neurol 106:1–19
Dusticier N, Nieoullon A (1987) Comparative analysis of the effects of in vivo electrical stimulation of the frontal cortex and γ-butyrolactone administration on dopamine and dihydroxyphenyl acetic acid (DOPAC) striatal contents in the rat. Neurochem Int 10:275–280
El Ganouni S, Forni C, Nieoullon A (1987) In vitro and in vivo characterization of the properties of a multifiber carbon electrode allowing long-term electrochemical detection of dopamine in freely moving animals. Brain Res 404:239–256
Fisher LJ, Young SJ, Tepper JM, Groves PM, Gage F. H. (1991) Electrophysiological characteristics of cells within mesencephalon suspension grafts. Neuroscience 40:109–122
Forni C (1982) Realization of a new multifiber electrochemical device allowing continuous in vivo measurements of neuromediators. J Neurosci Methods 5:167–171
Forni C, Nieoullon A (1984) Electrochemical detection of dopamine release in the striatum of freely moving hamsters. Brain Res 297:11–20
Forni C, Brundin P, Strecker RE, El Ganouni S, Björklund A, Nieoullon A (1989) Time-course of recovery of dopamine neuron activity during reinnervation of denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltametry. Exp Brain Res 76:75–87
Forni C, Dusticier N, Nieoullon A (1992) Further contribution to the study of corticostriatal glutamatergic and nigrostriatal dopaminergic interactions within the striatal network: an in vivo voltammetric investigation. Amino Acids 3:53–68
Freed W J (1991) Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials. Restor Neurol Neurosci 3:109–134
Gagnon C, Bedard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, Di Paolo T (1991) Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat. Brain Res 558:251–263
Galli T, Godeheu G, Artaud F, Desce JM, Pittaluga A, Barbeito L, Glowinski J, Cheramy A (1991) Specific role of N-acetyl aspartyl glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat. Neuroscience 42:19–28
Glowinski J, Barbeito L, Cheramy A (1991) Influence of corticostriatal glutamatergic neurons on dopaminergic transmission in the striatum. In: Bernardi G (ed) The basal ganglia III. Plenum, New York, pp 347–355
Gonon FG, Suaud-Chagny MF, Mermet CC, Buda M (1991) Relation between impulse flow and extracellular catecholamine levels as studied by in vivo electrochemistry in CNS. In: Fuxe K and Agnati LF (eds) Volume transmission in the brain: novel mechanisms for neural transmission. Raven, New York, pp 337–350
Herman JP, Choulli K, Le Moal M (1985) Activation of striatal dopaminergic grafts by haloperidol. Brain Res Bull 15:543–546
Herman JP, Lupp A, Abrous N, Le Moal M, Hertting G, Jackisch R (1988) Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons. Exp Brain Res 73:236–248
Herman JP, Choulli K, Abrous N, Le Moal M (1989) Intracerebral grafts of dopaminergic neurons: a discussion of their functional effects and mechanisms of actions. In: Gage F, Privat A, Christen Y (eds) Neuronal grafting and Alzheimer's disease, Foundation Ipsen. Springer, Berlin Heidelberg New York, pp 21–33
Herman JP, Rouge-Pont F, Le Moal M, Abrous DN (1993) Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis. Neuroscience 53:1083–1095
Herrera-Marschitz M (1991) Modulation of striatal dopamine and acetylcholine release by different glutamate receptors: studies with in vivo microdialysis. In: Bernardi G (ed) The basal ganglia III. Plenum, New York, pp 357–362
Imperato A and Di Chiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neuroscience 5:297–306
Imperato A, Mulas A, Di Chiara G (1987) The D1 antagonist SCH 23390 stimulates while the D1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur J Pharmacol 142:177–181
Imperato A, Di Chiara G (1988) Effects of locally applied D1 and D2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156:385–393
Imperato A, Honore T, Jensen LH (1990) Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely moving rats. Brain Res 530:223–228
Jackisch R, Duschek M, Neufang B, Rensing H, Hertting G, Herman JP (1991) Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine. J Neurochem 57:267–276
Keefe KA, Zigmond MJ, Abercrombie ED (1992) Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. 47:325–332
König JFR, Klippel RA (1963) The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem, Williams and Wilkins, Baltimore
Leanza G, Nilsson OG, Björklund A (1993) Functional activity of intrahippocampal septal grafts is regulated by catecholaminergic host afferents as studied by microdialysis of acetylcholine. Brain Res 618:47–56
Leviel V, Gobert A, Guibert B (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual-excitatory-inhibitory function. Neuroscience 39:305–312
Manier M, Abrous DN, Feuerstein C, Le Moal M, Herman JP (1991) Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis. Neuroscience 42:427–439
Martinez-Fong D, Rosales MG, Gongora-Alfaro JL, Hernandez S, Aceves J (1992) NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res 595:309–315
Mendez IM, Naus CCG, Elisevich K, Flumerfelt BA (1993) Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts. Exp Neurol 119:1–10
Mereu G, Costa E, Armstrong DM, Vicini S (1991) Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J Neurosci 11:1359–1366
Moghaddam B, Gruen RJ, Roth RH, Bunney BS, Adams RN (1990) Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res 518:55–60
Moghaddam B, Gruen RJ (1991) Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res 544:329–330
Moukhles H, Nieoullon A, Daszuta A (1992) Early and widespread normalization of dopamine-neuropeptide Y interaction in the rat striatum after transplantation of fetal mesencephalon cells. Neuroscience 4:781–792
Nieoullon A, Cheramy A, Glowinski J (1978) Release of dopamine evoked by the electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra of the rat Brain Res 145:69–83
Nieoullon A, Forni C, El Ganouni S (1986) Contribution to the study of nigrostriatal dopaminergic neuron activity using electrochemical detection of dopamine release in the striatum of freely moving animals. Ann NY Acad Sci 473:126–140
Nilsson OG, Kalen P, Rosengren E, Björklund A (1990) Acetylcholine release from intrahippocampal septal grafts is under control of the host brain. Proc Natl Acad Sci 87:2647–2651
Nishino H, Hashitani T, Kumazaki M, Sato H, Furuyama F, Isobe Y, Watari N, Kanai M, Shiosaka S (1990) Long-term survival grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Brain Res 534:83–93
Nishino H, Hashitani T, Kumazaki M (1991) Grafting of catecholaminergic cells in the mammalian brain and reconstruction of disturbed function: basic problems to be solved. Comp Biochem Physiol 98:211–220
Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U (1990) Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Exp Brain Res 82:293–303
Rioux L, Gaudin C, Bui LK, Gregoire L, Di Paolo T, Bedard PJ (1991) Correlation of functional recovery after 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat Neuroscience 4:123–131
Santiago M, Westerink BHC (1991) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J Neurochem 57:738–747
Savasta M, Mennicken F, Chritin M, Abrous DN, Feurstein C, Le Moal M, Herman JP (1992) Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptors densities caused by 6-OHDA lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience 46:729–738
Schmidt RH, Björklund A, Stenevi U, Dunnett SB, Gage FH (1983) Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol Scand [Suppl 522]: 19–28
See RE, Sorg BA, Chapman MA, Kalivas PW (1991) In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology 30:1269–1274
Segovia J, Meloni R, Gale K (1989) Effect of dopaminergic denervation and transplant-derived reinnervation on a marker of striatal GABAergic function. Brain Res 493:185–189
Segovia J, Castro R, Notario V, Gale K (1991) Transplants of fetal substantia nigra regulate glutamic acid decarboxylase gene expression in host striatal neurons. Mol Brain Res 10:359–362
Stamford JA (1989) In vivo voltammetry — prospects for the next decade. Trends Neurosci 12:407–412
Strecker RE, Sharp T, Brundin P, Zetterström T, Ungerstedt U, Björklund A (1987) Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 22:169–178
Wang JKT (1991) Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. J Neurochem 57:819–822
Weihmuller FB, O'Dell SJ, Cole BN, Marshall JF (1991) MK801 attenuates the dopamine-releasing but not the behavioral effects of metamphetamine. Brain Res 549:230–235
Westerink BHC, De Vries JB (1989) On the mechanisms of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197–202
Yurek DM, Sladek JR (1990) Dopamine cell replacement: Parkinson's disease. Ann Rev Neurosci 13:415–440
Zetterström T, Sharp T, Ungerstedt U (1985) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106:27–37
Zetterström T, Brundin P, Gage FH, Sharp T, Isacson O, Dunnett SB, Ungerstedt U, Björklund A (1986a) In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res 362:344–349
Zetterström T, Sharp T, Ungerstedt U (1986b) Effect of dopamine D1 and D2 receptor selective drugs on dopamine, release and metabolism in rat striatum in vivo. Naunyn Schmiedebergs Arch Pharmacol 334:117–124
Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290–296
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moukhles, H., Forni, C., Nieoullon, A. et al. Regulation of dopamine levels in intrastriatal grafts of fetal mesencephalic cell suspension: an in vivo voltammetric approach. Exp Brain Res 102, 10–20 (1994). https://doi.org/10.1007/BF00232434
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00232434